A new publication dated October 9, 2026 reports on antimicrobial peptoids related to LL-37 research. The study, titled "Antimicrobial Peptoids Show Potent Antifungal Activity against Candidozyma (Candida) auris In Vivo and Broad-Spectrum Activity In Vitro against Other Candida Species," appears in ACS Infectious Diseases. The publication is indexed under PubMed ID 42917104. LL-37 remains classified as an unapproved compound used only in research settings. This entry reflects the existence and bibliographic details of the publication as listed in the source record. No findings, efficacy data, or outcome summaries are included here beyond the title and journal information provided. Readers interested in the specific antifungal results described in the study should consult the original publication directly through the listed source. This brief serves only to note that the publication has been released and indexed, without characterizing its conclusions. For additional background on LL-37, including its general research classification and regulatory status, readers can consult the compound overview.
LL-37-Related Peptoid Study Published on Antifungal Activity vs Candida
Source: https://pubmed.ncbi.nlm.nih.gov/42917104/